Table 2.
MiRNA | Blood donors (n = 20) | Without DR (n = 91) | P valueb | NPDR (n = 46) | PDR (n = 49) | P valuec |
---|---|---|---|---|---|---|
miR‐29b (log2 FC) | –1.79 (−2.14 to −1.19) | –1.16 (−2.32 to −0.35) | 0.073 | –1.66 (−2.89 to −0.27) | –1.91 (−2.54 to −1.23)d | 0.022 |
miR‐200b (log2 FC)a | 0.68 (0.10‐0.92) | –0.41 (−1.11 to 0.67) | 0.001 | –0.69 (−1.64 to 0.07) | –0.91 (−1.98 to 0.09) | 0.078 |
Data are shown as median (25th‐75th percentiles).
FC, fold change.
Data available for 179 type 2 diabetic patients (four patients without DR, one with NPDR and two with PDR had undetectable levels).
Comparison of diabetic patients without DR and blood donors.
Comparison of diabetic patients with PDR, NPDR and without DR.
Significantly different from the group without DR after correction for pairwise multiple comparisons (P < 0.05, Tukey test).